Supression of germline editing is a tragedy
// note
Harder to charge insurance $10M for an embryo that isn't even a "human" yet
If germline editing ever does somehow pass an ethics & safety review, pharma co's will find a way to kill it
Comments
Loading…
Subscribe to get new essays in your inbox.
Continue Reading
Line Drawings in Cognition
On Sayim & Cavanagh (https://www.frontiersin.org/articles/10.3389/fnhum.2011.00118/abstract) Perspective on line drawings, how they are significant: --> via learned neural codes that spark understanding of an object (the…
margin expansion for hims & hers ($HIMS)
market seems to think hims is cooked b/c margins on non-glp1 services are low this is true however, they are not as bad as people think from my experience working in d2c pharmacy space, i know gross margins working w/ a …
Enzymology
Enzymology Mark Namchuk - Vertex Vertex x Chinese labs mega study: - Target validation (human genetics + molbio) BUT, if you don’t link it to the therapeutic intervention, 2/3s don’t work! - Need to separate and actually…